clarithromycin has been researched along with Toxoplasmosis, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Della Bruna, C; Gorini, G; Jabes, D; Marchetti, A; Olliaro, P; Regazzetti, A; Rossi, R; Tinelli, C | 1 |
| Alder, J; Clement, JC; Hutch, T; Meulbroek, JA | 1 |
| Derouin, F; Pudney, M; Romand, S | 1 |
| Berg-Candolfi, M; Candolfi, E | 1 |
| Araujo, FG; Khan, AA; Polzer, RJ; Remington, JS; Slifer, T | 1 |
| Caroff, B; Chau, F; Derouin, F; Pocidalo, JJ; Prokocimer, P | 1 |
| Araujo, FG; Lin, T; Prokocimer, P; Remington, JS | 1 |
| Araujo, FG; Prokocimer, P; Remington, JS | 1 |
| Chang, HR; Pechère, JC; Rudareanu, FC | 1 |
9 other study(ies) available for clarithromycin and Toxoplasmosis, Animal
| Article | Year |
|---|---|
In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii.
Topics: Animals; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Female; Mice; Rifabutin; Toxoplasma; Toxoplasmosis, Animal | 1994 |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Topics: AIDS-Related Opportunistic Infections; Animals; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mice; Minocycline; Pyrimethamine; Sulfamethoxazole; Toxoplasma; Toxoplasmosis, Animal | 1994 |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Clarithromycin; Coccidiostats; Drug Combinations; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Kinetics; Mice; Minocycline; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1993 |
Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Clindamycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Intestinal Mucosa; Jejunum; Kinetics; Mice; Microsomes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Reference Values; Time Factors; Toxoplasmosis, Animal | 1996 |
Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Area Under Curve; Atovaquone; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Fluoroquinolones; Mice; Naphthoquinones; Naphthyridines; Rifabutin; Tissue Distribution; Toxoplasmosis, Animal | 1997 |
Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis.
Topics: Animals; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Mice; Minocycline; Toxoplasmosis, Animal | 1992 |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Animals; Brain Diseases; Chronic Disease; Clarithromycin; Cysts; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred CBA; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1992 |
Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Minocycline; Toxoplasmosis, Animal | 1992 |
Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
Topics: Animals; Clarithromycin; Erythromycin; Female; Mice; Mice, Inbred Strains; Toxoplasma; Toxoplasmosis, Animal | 1988 |